Cymabay Therapeutics Inc (CBAY) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cymabay Therapeutics Inc   (NASDAQ: CBAY)


Cymabay Therapeutics Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cymabay Therapeutics Inc's ROI in the fourth quarter of 2023?
Cymabay Therapeutics Inc recorded a cumulative net loss of $-105 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -34.08%.

Within the Healthcare sector 440 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 3726 to 3880.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM 97.98 % 41.5 % 5.2 % 7.99 % 17.43 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 398 431 209 199 126
Return On Investment (TTM) -34.08 % -37.33 % -47.45 % -67.2 % -67.87 %
CBAY's Overall Ranking # 3880 # 3726 # 3387 # 3591 # 4130
Seq. Investment Change TTM 28.12 % 41.86 % 6.84 % 1.96 % -8.43 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -105 -90 -81 -107 -106

CBAY Company Profile >> Back to CBAY Roi Comparisons >> See Annual CBAY Return On Investment



Return On Investment CBAY's Ranking
Within: No.
Industry # 171
Sector # 441
Overall # 3880

Return On Investment Statistics
High Average Low
-32.21 %
-83.91 %
-265.22 %
(Jun 30 2018)   (Sep 30 2016)







Financial Statements
Cymabay Therapeutics Inc's IV. Quarter Investments $ 398 Millions CBAY's Balance sheet
Cymabay Therapeutics Inc's IV. Quarter Income $ -42 Millions Quarterly CBAY's Income Statement
CBAY's Income by Division See CBAY's Income by Division


CBAY Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 398 126 184 144 190
Y / Y Investment Growth 214.72 % -31.28 % 27.77 % -24.04 % 9.99 %
Net Income in Millions -105 -106 -90 -51 -103
Y / Y Net Income Growth - - - - -
Annual Return On Investment -26.49 % -83.85 % -48.92 % -35.41 % -54.24 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CBAY's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CBAY's Competitors
Subscribers only: Roi for Cymabay Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CBAY's Customers

Other Ratios
CBAY's Roa CBAY's Inventory Turnover Ratio CBAY's Growth Rates CBAY's Dividend Statistics
CBAY's Profitability Ratios CBAY's Asset Turnover Ratio CBAY's Dividend Growth
CBAY's Roe CBAY's Valuation Ratios CBAY's Financial Strength Ratios CBAY's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.